Table 2.
The serum index of case and control group in the second trimester of pregnancy
| Variables | Case (n = 66) | Control (n = 66) | t | P |
|---|---|---|---|---|
| FPG (mmol/L) | 4.94 ± 0.55 | 4.60 ± 0.35 | 4.348 | < 0.001 |
| OGTT 1hPG (mmol/L) | 9.82 ± 1.95 | 7.25 ± 1.46 | 8.181 | < 0.001 |
| OGTT 2hPG (mmol/L) | 8.56 ± 2.12 | 6.57 ± 1.39 | 6.839 | < 0.001 |
| AUCGlucose[mmol/(L • h)] | 16.20 ± 3.82 | 12.84 ± 1.98 | 6.426 | < 0.001 |
| Fasting insulin (μIU/mL) | 13.26 ± 10.72 | 13.19 ± 8.65 | 0.039 | 0.969 |
| HOMA-IR | 2.98 ± 2.51 | 2.41 ± 1.93 | 1.457 | 0.150 |
| TC (mmol/L) | 5.70 ± 1.04 | 6.19 ± 1.35 | -2.101 | 0.024 |
| TG (mmol/L) | 2.82 ± 1.16 | 2.46 ± 0.84 | 1.992 | 0.051 |
| HDL-C (mmol/L) | 1.62 ± 0.33 | 1.78 ± 0.43 | -2.315 | 0.256 |
| LDL-C (mmol/L) | 3.12 ± 0.76 | 3.30 ± 1.00 | -1.147 | 0.051 |
| Val (μmol/L) | 171.18 ± 50.42 | 154.20 ± 39.40 | 2.110 | 0.039 |
| Ile (μmol/L) | 96.58 ± 47.70 | 88.89 ± 42.99 | 0.979 | 0.331 |
| Leu (μmol/L) | 130.68 ± 42.34 | 129.02 ± 42.36 | 0.221 | 0.826 |
| mTOR (ng/mL) | 20.13 ± 6.97 | 17.84 ± 4.95 | 2.090 | 0.041 |
Abbreviation: FPG fasting plasma glucose, OGTT oral glucose tolerance test, 1hPG 1 h plasma glucose, 2hPG 2 h plasma glucose, AUC area under curve, HOMA-IR homeostasis model assessment of insulin resistance, TC total cholesterol, TG triglyceride, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, Val valine, Ile isoleuline, Leu leucine, mTOR mammalian target of rapamycin